Human Papillomavirus Infection

• EMA approval · 2025-10-20
  EMA Authorised: Gardasil (human papillomavirus type 6 L1 protein;human papillomavirus type 11 L1 protein;human papillomavirus type 16 L1 protein;human papillomavirus type 18 L1 protein) — Merck Sharp & Dohme B.V.

  The EMA authorised Gardasil, a quadrivalent human papillomavirus vaccine, for prevention of HPV infections and related diseases such as cerv…

• EMA approval · 2025-10-09
  EMA Authorised: Gardasil 9 (human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed)) — Merck Sharp & Dohme B.V.

  The European Medicines Agency authorised Gardasil 9, a human papillomavirus vaccine. It is indicated for preventing HPV-related conditions i…

• EMA approval · 2024-11-26
  EMA Authorised: Cervarix (human papillomavirus1 type 16 L1 protein;human papillomavirus type 18 L1 protein) — GlaxoSmithKline Biologicals S.A.

  The European Medicines Agency authorised Cervarix, an HPV vaccine targeting types 16 and 18, for immunization to prevent papillomavirus infe…